Medicare immunosuppressant coverage and access to kidney transplantation: A retrospective national cohort study

Vanessa Grubbs, Laura C. Plantinga, Eric Vittinghoff, Ann M. Ohare, R. Adams Dudley

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Abstract. Background: In December 2000, Medicare eliminated time limitations in immunosuppressant coverage after kidney transplant for beneficiaries age 65 and those who were disabled. This change did not apply to younger non-disabled beneficiaries who qualified for Medicare only because of their end-stage renal disease (ESRD). We sought to examine access to waitlisting for kidney transplantation in a cohort spanning this policy change. Methods. This was a retrospective cohort analysis of 241,150 Medicare beneficiaries in the United States Renal Data System who initiated chronic dialysis between 1/1/96 and 11/30/03. We fit interrupted time series Cox proportional hazard models to compare access to kidney transplant waitlist within 12months of initiating chronic dialysis by age/disability status, accounting for secular trends. Results: Beneficiaries age <65 who were not disabled were less likely to be waitlisted after the policy change (hazard ratio (HR) for the later vs. earlier period, 0.93, p=0.002), after adjusting for sociodemographic factors, co-morbid conditions, income, and ESRD network. There was no evidence of secular trend in this group (HR per year, 1.00, p=0.989). Likelihood of being waitlisted among those age 65 or disabled increased steadily throughout the study period (HR per year, 1.04, p<0.001), but was not clearly affected by the policy change (HR for the immediate effect of policy change, 0.93, p=0.135). Conclusions: The most recent extension in Medicare immunosuppressant coverage appears to have had little impact on the already increasing access to waitlisting among 65/ disabled beneficiaries eligible for the benefit but may have decreased access for younger, non-disabled beneficiaries who were not. The potential ramifications of policies on candidacy appeal for access to kidney transplantation should be considered.

Original languageEnglish (US)
Article number254
JournalBMC Health Services Research
Volume12
Issue number1
DOIs
StatePublished - 2012
Externally publishedYes

Bibliographical note

Funding Information:
VG was supported by National Institutes of Health/ National Institute of Diabetes and Digestive and Renal Diseases Diversity Supplement to R01 DK70939 and by the Harold Amos Medical Faculty Development Program of the Robert Wood Johnson Foundation. RAD was supported by an Investigator Award in Health Policy from the Robert Wood Johnson Foundation.

Fingerprint

Dive into the research topics of 'Medicare immunosuppressant coverage and access to kidney transplantation: A retrospective national cohort study'. Together they form a unique fingerprint.

Cite this